Dr Ndubuisi Chiamaka Okafor, MD - Medicare Pulmonary Disease in Cookeville, TN

Dr Ndubuisi Chiamaka Okafor, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Cookeville, Tennessee. He graduated from medical school in 2004 and has 20 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Dhanvan Llc, Holy Cross Medical Group and his current practice location is 145 W 4th St, Suite 102, Cookeville, Tennessee. You can reach out to his office (for appointments etc.) via phone at (931) 783-2143.

Dr Ndubuisi Chiamaka Okafor is licensed to practice in Tennessee (license number 48815) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1831346238.

Contact Information

Dr Ndubuisi Chiamaka Okafor, MD
145 W 4th St, Suite 102,
Cookeville, TN 38501-2447
(931) 783-2143
(931) 783-2152



Physician's Profile

Full NameDr Ndubuisi Chiamaka Okafor
GenderMale
SpecialityPulmonary Disease
Experience20 Years
Location145 W 4th St, Cookeville, Tennessee
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Ndubuisi Chiamaka Okafor graduated from medical school in 2004
  NPI Data:
  • NPI Number: 1831346238
  • Provider Enumeration Date: 08/27/2008
  • Last Update Date: 05/19/2015
  Medicare PECOS Information:
  • PECOS PAC ID: 9739375965
  • Enrollment ID: I20151111000694

Medical Identifiers

Medical identifiers for Dr Ndubuisi Chiamaka Okafor such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1831346238NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease 48815 (Tennessee)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Broward Health Medical CenterFort lauderdale, FLHospital
Holy Cross HospitalFort lauderdale, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Dhanvan Llc115365410810
Holy Cross Medical Group1850298365194

News Archive

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Ndubuisi Chiamaka Okafor allows following entities to bill medicare on his behalf.
Entity NameHoly Cross Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467401877
PECOS PAC ID: 1850298365
Enrollment ID: O20031215000087

News Archive

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

Read more Medical News

› Verified 9 days ago

Entity NameIntensive Care Consortium Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629019062
PECOS PAC ID: 0244269413
Enrollment ID: O20050808000883

News Archive

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

Read more Medical News

› Verified 9 days ago

Entity NameDhanvan Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942772330
PECOS PAC ID: 1153654108
Enrollment ID: O20190606002616

News Archive

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ndubuisi Chiamaka Okafor is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Ndubuisi Chiamaka Okafor, MD
127 N Oak Ave, Suite D,
Cookeville, TN 38501-2435

Ph: (931) 783-5857
Dr Ndubuisi Chiamaka Okafor, MD
145 W 4th St, Suite 102,
Cookeville, TN 38501-2447

Ph: (931) 783-2143

News Archive

Pfizer's new chewable Lipitor for children receives European Commission approval

Pfizer Inc. announced it has received European Commission approval of a new chewable form of Lipitor (atorvastatin calcium) suitable for use in children aged 10 or older with high levels of LDL ("bad") cholesterol and high triglycerides due to the inherited disorder familial hypercholesterolemia and other primary causes, which can increase the risk of heart disease and premature death. This pediatric indication has also been approved for the currently available tablet form of Lipitor.

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

Gene research offers new hope for targeted breast cancer treatment

CANCER RESEARCH UK scientists have developed a system to identify faulty or missing genes that could prevent specific chemotherapy regimes from working. This opens the doors for targeted breast cancer treatment, according to research published in the Lancet Oncology* today (Monday).

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

Read more News

› Verified 9 days ago


Internal Medicine Doctors in Cookeville, TN

Scott F Reising, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501
Phone: 931-372-0405    Fax: 931-372-0463
Stacy David Brewington, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 228 W. 4th Street, Suite 200, Cookeville, TN 38501
Phone: 931-372-0405    Fax: 931-372-0463
Mark Arden Pierce, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 145 W 4th St, Suite 201, Cookeville, TN 38501
Phone: 931-783-2902    Fax: 931-783-2219
Michael Blaine Lenhart, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 228 West 4th St, Suite 200, Cookeville, TN 38501
Phone: 931-372-0405    Fax: 931-372-0463
Dr. Toney Britton Hudson, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 315 N Washington Ave, Ste 165, Cookeville, TN 38501
Phone: 931-526-1604    Fax: 931-526-7378
James Chike Ezi-ashi, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 438 N Whitney Ave, Cookeville, TN 38501
Phone: 931-783-2616    Fax: 931-783-2610
Dr. Brian Keith Dockery, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 228 W 4th St, Suite 200, Cookeville, TN 38501
Phone: 931-372-0405    Fax: 931-372-0463

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.